insights_auto
Pse është ulur PTKFY 15,18%?
Zhytu më thellëchevron_right
PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
7,21Â US$
arrow_downward
-15,18%(-1,29) 1D
19 tet, 11:03:56 p.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për PTKFY...
Hap
7,46Â US$
I lartë
7,46Â US$
I ulët
7,21Â US$
Kapitalizimi i tregut
30,66Â bln
Vëllimi mesatar
1,94 mijë
Vëllimi
292,00
Maksimumi 52-javor
16,36Â US$
Minimumi 52-javor
7,21Â US$
Beta
0,09
Aksionet në qarkullim
234,07Â mln
Numri i punonjësve
13 mijë
Hap
7,46Â US$
I lartë
7,46Â US$
I ulët
7,21Â US$
Kapitalizimi i tregut
30,66Â bln
Vëllimi mesatar
1,94 mijë
Vëllimi
292,00
Maksimumi 52-javor
16,36Â US$
Minimumi 52-javor
7,21Â US$
Beta
0,09
Aksionet në qarkullim
234,07Â mln
Numri i punonjësve
13 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
2 orë më parë
Kalbe Farma stock: UOB cites IDR 770 for Kalbe Farma stock
ad-hoc-news.de
·
8 orë më parë
Kalbe Farma cancels IDR 500 billion buyback for Kalbe Farma stock
ad-hoc-news.de
·
9 orë më parë
Kalbe Farma stock pre-market ahead of the Xetra open
Profili
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Rreth PT Kalbe Farma Unsponsored Indonesia ADR